This is a pretty simplistic view, the article talks about a different Surgisphere study where the conclusion is that a cheap and widely available drug is effective against covid-19 (the study also has its problems though):
"A third COVID-19 study using Surgisphere data has also drawn fire. In a preprint first posted in early April, Surgisphere founder and CEO Sapan Desai and co-authors conclude that ivermectin, an antiparasitic drug, dramatically reduced mortality in COVID-19 patients. In Latin America, where ivermectin is widely available, that study has led government officials to authorize the drug—although with precautions—creating a surge in demand in several countries."
I pointed out the Johnson and Johnson relationship only to say motives should be examined.
Surgisphere is producing studies based on data they don't actually have, according to researchers, Australian hospitals, etc. It could be for self-aggrandizement, or pay-for-publish or something else. I don't know, but it should not be tolerated for any reason.
"A third COVID-19 study using Surgisphere data has also drawn fire. In a preprint first posted in early April, Surgisphere founder and CEO Sapan Desai and co-authors conclude that ivermectin, an antiparasitic drug, dramatically reduced mortality in COVID-19 patients. In Latin America, where ivermectin is widely available, that study has led government officials to authorize the drug—although with precautions—creating a surge in demand in several countries."